and the advancement of brepocitinib to Phase 3 trials for non-infectious uveitis, a form of eye inflammation. Roivant ...

Background Non-infectious uveitis is a diverse group of inflammatory conditions that collectively account for substantial blindness worldwide. Expert guidelines and results of clinical trials guide ...

Die Investmentfirma H.C. Wainwright bekräftigte am Dienstag ihre positive Einschätzung für die Aktien von Kiora Pharmaceuticals (NASDAQ:KPRX) und bestätigte sowohl die Kaufempfehlung als auch das Kurs ...

Am Dienstag bestätigte H.C. Wainwright seine Kaufempfehlung und das Kursziel von 10,00 US-Dollar für Kiora Pharmaceuticals (NASDAQ:KPRX) nach der Veröffentlichung des Finanzberichts für das dritte Qua ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

The three most common types of inflammatory eye disease were keratitis (26 cases, or 33%), uveitis (25 cases, or 32%), and ...

Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown ...

Shelley Kline has spent four decades dealing with pain, medication, and traumatic procedures for her eye disease. She knows ...

Whereas 89.5% of new prescriptions for disease-modifying anti-rheumatic drugs (DMARDs) in 2000 were for old-line agents, by ...

A diagnostic delay of 2 to 6 years may be typical in axSpA, noted Raj Sengupta, MBBS, of the University of Bath in England, ...

Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - ...

Q3 2024 Earnings Call Transcript November 8, 2024 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.34, expectations were $1.09. Operator: Good day, everyone, and welcome to ...